Hassan Hamandi

Director, Pediatric IBD Program, Associate Professor of Pediatrics and Medicine, UCLA. Opinions are my own. Tweets are not medical advice.

[Hassan Hamandi @HassanHamandi]

UCLA IBD Transition Clinic is here!

[UCLA Gastroenterology and Hepatology @UCLAGIHep]

✍️Accepting applications for the 2027-28 Advanced #IBD Fellowship Program thru July 15! Centered within a high-volume, multidisciplinary IBD program, the fellowship offers a tailored blend of advanced clinical training & research development.

👉Learn more https://t.co/jh745LehKQ

[Hassan Hamandi @HassanHamandi]

Take Steps @CrohnsColitisFn
@UCLAibd Let’s find the cure!

[Bowel Sounds: The Pediatric GI Podcast @bowelsounds]

🎙️ New episode: Addressing Women’s Health in Pediatric IBD! From delayed puberty to contraception to fertility after surgery
🎧 CME credit available! #MedEd #IBD #WomensHealth #PedsGI #FOAMed

https://t.co/vl4TSev22l

[Hassan Hamandi @HassanHamandi]

Thank you @CrohnsColitisFn for an amazing Take Steps event!

And @UCLAHealth for your support!

[Hassan Hamandi @HassanHamandi]

Our fellows being rockstars at DDW!
@DDWMeeting

[American Academy of Pediatrics @AmerAcadPeds]

AAP joined @AAFP, @ACOG, @ACPIMPhysicians, @AOAforDOs and @APApsychiatric in urging the U.S. government to remain in the World Health Organization. Read the statement: https://t.co/L3EU9eRG4d

[Gastroenterology & Endoscopy News @gastroendonews]

New study shows patients on GLP-1s have prolonged gastric transit time and incomplete small bowel evaluation during endoscopy, raising concerns about delayed gastric emptying and highlighting the need for more research. @tarek_odahMD

https://t.co/3zFMbFLL90

[Hassan Hamandi @HassanHamandi]

Happy Holidays from the UCLA Pediatric IBD Team! @UCLA @UCLAibd @UCLAMCH

[Hassan Hamandi @HassanHamandi]

On Giving Tuesday, think of children living with chronic illnesses such as Inflammatory Bowel Disease 🙌🏽

https://t.co/F70LePvdmv

[UCLA @UCLA]

UCLA has been ranked the nation’s #1 public university by @USNews and World Report! 8 years in a row and it’s all thanks to you, Bruins.💙🐻💛 #1UCLA

Learn more: https://t.co/CX9oy2UXEh

[Gastroenterology & Endoscopy News @gastroendonews]

Guselkumab induced higher levels of clinical and endoscopic remission than placebo and ustekinumab in the GALAXI phase 2/3 trial. @RPanaccione @IBDCalgary @MRegueiroMD @clevelandclinic #IBDTwitter #IBD
https://t.co/kn1aMWghBy

[JPGN @JPGNonline]

Dual biological therapy shows promise for treating children with severe, refractory #IBD.

✅ 45% achieved clinical remission within 12 months, offering a potential alternative for those failing previous treatments. #Pediatrics #Gastroenterology

https://t.co/xJJIHqrgRT

[UCLA Gastroenterology and Hepatology @UCLAGIHep]

🌠#UCLAGI & GI surgery ranked #4 in @USNews Best Hospitals rankings! This also makes us the top ranked GI & GI surgery hospital for a public university in the country. We thank our patients for continuing to choose our dedicated and exemplary team to provide their care.

[Uma Mahadevan @UmaMahadevanIBD]

Hot of the press: Upadacitinib safety in pregnancy. 128 maternal pregnacies all exposed in the first trimester primarily. @MotherToBaby @JulsgaardMette @MLongMD https://t.co/QDaAG6w6hs

[Gastroenterology & Endoscopy News @gastroendonews]

Check out @MRegueiroMD highlight some of his favorite #IBD research at #DDW2024. Click the link to watch the full video! https://t.co/bxviBunoWD

[Bowel Sounds: The Pediatric GI Podcast @bowelsounds]

🎧All New Episode:

Dr. Maria Oliva-Hemker @molivahemker from John Hopkins @HopkinsMedicine talks about #cdiff:

🎙️How to manage C. diff infection in #IBD
🎙️The history of C.diff
🎙️How C.diff changed from Clostridium difficile to Clostridioides difficile ✍️

@temarahajjat @PLLU

[Uma Mahadevan @UmaMahadevanIBD]

Anecdotally, many of us have noted improvement in IBD in setting of PSC with oral vancomycin. This study in @APandT provides some support. @amandaricciuto https://t.co/oJUMAEVi60

[Stanford Childrens Center for IBD & Celiac Disease @SMCH_IBD_Celiac]

Congrats to our adv IBD Fellow @patelperseus on publication of his work in @JPGNonline showing similar effectiveness of VDZ and UST in pediatric UC patients with prior TNFi exposure! @melheyman @ImproveCareNow https://t.co/LGSnLzOh1r

[American Gastroenterological Association (AGA) @AmerGastroAssn]

Good morning from Washington, D.C.! We’re joining @FightCRC and partners in the CRC community to raise awareness about the need to increase and protect access to screening.
#UnitedInBlue